Skip to main content

Table 2 Hazard ratios for death and MACCE associated with treatment strategies

From: Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China

 

MT group (N = 913)

PCI group (N = 1305)

CABG group (N = 899)

HR (95% CI)

P value

HR (95% CI)

P value

HR (95% CI)

P value

Death

 Crude Model

1.00 (ref)

0.33 (0.27, 0.40)

 < 0.0001

0.34 (0.27, 0.42)

 < 0.0001

 Multivariate adjusted Model

1.00 (ref)

0.40 (0.32, 0.51)

 < 0.0001

0.33 (0.26, 0.44)

 < 0.0001

 Crude Model

3.03 (2.51, 3.66)

 < 0.0001

1.00 (ref)

1.03 (0.81, 1.30)

0.8396

 Multivariate adjusted Model

2.50 (1.98, 3.16)

 < 0.0001

1.00 (ref)

0.83 (0.62, 1.12)

0.2215

MACCE

 Crude Model

1.00 (ref)

 

0.66 (0.58, 0.75)

 < 0.0001

0.48 (0.41, 0.57)

 < 0.0001

 Multivariate adjusted Model

1.00 (ref)

 

0.71 (0.60, 0.84)

 < 0.0001

0.48 (0.39, 0.57)

 < 0.0001

 Crude Model

1.52 (1.33, 1.73)

 < 0.0001

1.00 (ref)

0.73 (0.62, 0.86)

0.0001

 Multivariate adjusted Model

1.41 (1.20, 1.66)

 < 0.0001

1.00 (ref)

0.67 (0.55, 0.81)

 < 0.0001

  1. MACCE major adverse cardiac and cerebrovascular events, HR hazard ratios, MT medical treatment, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting